AKT1 and lymphoma: In our current study, we confirmed that CLP36 silencing could diminish the phosphorylation of PI3K, AKT and CREB in lymphoma cells, thus indicating the targeting relationship between CLP36 and PI3K/AKT/CREB axis in lymphoma.